XML 73 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Revenue, net of contractual discounts $ 1,689,805 $ 1,444,131 $ 3,295,053 $ 2,851,921
Provision for uncompensated care (790,550) (643,033) (1,507,474) (1,244,529)
Net revenue 899,255 801,098 1,787,579 1,607,392
Compensation and benefits 643,960 562,838 1,285,749 1,128,703
Operating expenses 102,288 96,807 202,671 204,388
Insurance expense 25,840 27,555 51,673 52,445
Selling, general and administrative expenses 23,789 20,136 45,787 39,129
Depreciation and amortization expense 34,622 30,762 69,377 61,252
Restructuring charges 3,032 2,744 3,669 8,723
Income from operations 65,724 60,256 128,653 112,752
Interest income from restricted assets 266 258 632 545
Interest expense (38,538) (41,514) (78,828) (84,966)
Realized gain on investments 105 63 118 361
Interest and other (expense) income (249) 241 (12,970) 403
Loss on early debt extinguishment   (5,172) (122) (5,172)
Income before income taxes, equity in earnings of unconsolidated subsidiary, and noncontrolling interest 27,308 14,132 37,483 23,923
Income tax expense (10,832) (6,266) (17,966) (10,504)
Income before equity in earnings of unconsolidated subsidiary and noncontrolling interest 16,476 7,866 19,517 13,419
Equity in earnings of unconsolidated subsidiary 87 105 162 214
Net income attributable to noncontrolling interest   (130)    
Net income attributable to Envision Healthcare Corporation 16,563 7,841 19,679 13,633
Other comprehensive income (loss), net of tax:        
Unrealized holding (losses) gains during the period (13) 161 (449) 203
Unrealized gains (losses) on derivative financial instruments 20 (1,254) (278) (1,265)
Comprehensive income $ 16,570 $ 6,748 $ 18,952 $ 12,571